[1] |
Sano A, Kato H, Sakurai S, et al. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma[J]. Ann Surg Oncol, 2009,16(2):506-514.
|
[2] |
Ren Y, Cao B, Law S, et al. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas[J]. Clin Cancer Res, 2005,11(17):6190-6197.
|
[3] |
Mariette C, Balon JM, Piessen G, et al. Pattern of recurrence following complete resection of esophageal carcinoma and factors predictive of recurrent disease[J]. Cancer, 2003,97(7):1616-1623.
|
[4] |
Law S, Kwong DL, Kwok KF, et al. Improvement in treatment results and long-term survival of patients with esophageal cancer: impact of chemoradiation and change in treatment strategy[J]. Ann Surg, 2003,238(3):339-347.
|
[5] |
Okawa T, Naomoto Y, Nobuhisa T, et al. Heparanase is involved in angiogenesis in esophageal cancer through induction of cyclooxygenase-2[J]. Clin Cancer Res, 2005;11(22):7995-8005.
|
[6] |
Shih CH, Ozawa S, Ando N, et al. Vascular endothelial growth factor expression predicts outcome and lymph node metastasis in squamous cell carcinoma of the esophagus[J]. Clin Cancer Res, 2000;6(3):1161-1168.
|
[7] |
Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004,116(2):281-297.
|
[8] |
Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs down regulate large numbers of target mRNAs[J]. Nature, 2005,433(7027):769-773.
|
[9] |
Dykxhoorn DM. MicroRNAs and metastasis: little RNAs go a long way[J]. Cancer Res, 2010,70(16):6401-6406.
|
[10] |
Calin GA, Croce CM. MicroRNA signatures in human cancers[J]. Nat Rev Cancer, 2006,6(11):857-866.
|
[11] |
Lovat F, Valeri N, Croce CM. Micro-RNAs in the pathogenesis of cancer[J]. Semin Oncol, 2011,38(6):724-733.
|
[12] |
Chen PS, Su JL, Hung MC. Dysregulation of microRNAs in cancer[J]. J Biomed Sci, 2012,19:90.
|
[13] |
贾筱琴,缪俊俊,雍军,等.miR-148a对肝癌细胞株侵袭和迁移的抑制作用及机制[J].中国癌症杂志,2014,24(6):412-417.
|
[14] |
Chen Y, Song Y, Wang Z, et al. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance[J]. J Gastrointest Surg, 2010,14(7):1170-1179.
|
[15] |
Hummel R, Watson DI, Smith C, et al. Mir-148a improves response to chemotherapy in sensitive and resis-tant oesophageal adenocarcinoma and squamous cell carcinoma cells[J]. J Gastrointest Surg, 2011,15(3):429-438.
|
[16] |
Zhang H, Li Y, Huang Q, et al. MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer[J]. Cell Death Differ, 2011,18(11):1702-1710.
|
[17] |
Takahashi M, Cuatrecasas M, Balaguer F, et al. The clinical significance of MiR-148a as a predictive biomarker in patients with advanced colorectal cancer[J]. PLoS One, 2012,7(10):e46684.
|
[18] |
Korst RJ, Rusch VW, Venkatraman E, et al. Proposed revision of the staging classification for esophageal cancer[J]. J Thorac Cardiovasc Surg, 1998;115(3):660- 669.
|
[19] |
Hamilton SR, Aaltonen LA. Tumours of the digestive system[M]//Pathology and Genetics, World Health Organization Classification of Tumours. Lyon:IARC Press, 2000:10-25.
|
[20] |
Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook[M]. 6th ed. New York: Springer-Verlag, 2002:91-98.
|
[21] |
Fujita Y, Kojima K, Ohhashi R, et al. MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression[J]. J Biol Chem, 2010,285(25):19076-19084.
|
[22] |
Murata T, Takayama K, Katayama S, et al. miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression[J]. Prostate Cancer Prostatic Dis, 2010,13(4):356-361.
|
[23] |
邱光庭,王遂函,李大鹏,等.微小RNA-148a对胃癌细胞MKN45增殖能力的影响及机制研究[J].中华胃肠外科杂志,2014,17(10):1036-1039.
|
[24] |
Bofill-De Ros X, Gironella M, Fillat C. miR-148a- and miR-216a-regulated oncolytic adenoviruses targeting pancreatic tumors attenuate tissue damage without perturbation of miRNA activity[J]. Mol Ther, 2014,22(9):1665-1677.
|
[25] |
Tao S, He H, Chen Q, et al. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer[J]. Biochem Biophys Res Commun, 2014,451(1):74-78.
|
[26] |
Zhou X, Zhao F, Wang ZN, et al. Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation[J]. Oncol Rep, 2012,27(2):447-454.
|